CD4 and melanoma: On the other hand, vaccination with a mixture of 6 HLA-DR- restricted melanoma helper peptides induced both specific Th1-dominant CD4+ T cell responses and Ab responses, associated with improved overall survival among patients with metastatic melanoma [43, 44].